Generics Global Industry Almanac 2013-2022

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:

– What was the size of the global generics market by value in 2017?

– What will be the size of the global generics market in 2022?

– What factors are affecting the strength of competition in the global generics market?

– How has the market performed over the last five years?

– How large is the global generics market in relation to its regional counterparts?

Scope

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

– For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

– The market value is evaluated at ex-factory prices.

– Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.

– Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.

– Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.

– All currency conversions were calculated at constant average annual 2017 exchange rates.

– The global generics market had total revenues of $307.6bn in 2017, representing a compound annual growth rate (CAGR) of 8.2% between 2013 and 2017.

– Market consumption volume increased with a CAGR of 1.9% between 2013 and 2017, to reach a total of 70.2% in 2017.

– The US is the largest market in the world; it made up 33.5% of the global value in 2017. Other large markets include China, Japan, Germany, and India.

Reasons to buy

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market

- Leading company profiles reveal details of key generics market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Table of Contents

Table of Contents

EXECUTIVE SUMMARY 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Geography segmentation 2

Introduction 32

What is this report about? 32

Who is the target reader? 32

How to use this report 32

Definitions 32

Global Generics 33

Market Overview 33

Market Data 35

Market Segmentation 37

Market outlook 38

Five forces analysis 40

Generics in Asia-Pacific 46

Market Overview 46

Market Data 48

Market Segmentation 50

Market outlook 51

Five forces analysis 53

Generics in Europe 59

Market Overview 59

Market Data 61

Market Segmentation 63

Market outlook 64

Five forces analysis 66

Generics in France 72

Market Overview 72

Market Data 73

Market Segmentation 75

Market outlook 76

Five forces analysis 78

Macroeconomic indicators 84

Generics in Germany 86

Market Overview 86

Market Data 87

Market Segmentation 89

Market outlook 90

Five forces analysis 92

Macroeconomic indicators 98

Generics in Australia 100

Market Overview 100

Market Data 101

Market Segmentation 103

Market outlook 104

Five forces analysis 106

Macroeconomic indicators 112

Generics in Brazil 114

Market Overview 114

Market Data 115

Market Segmentation 117

Market outlook 118

Five forces analysis 120

Macroeconomic indicators 126

Generics in Canada 128

Market Overview 128

Market Data 129

Market Segmentation 131

Market outlook 132

Five forces analysis 134

Macroeconomic indicators 141

Generics in China 143

Market Overview 143

Market Data 144

Market Segmentation 146

Market outlook 147

Five forces analysis 149

Macroeconomic indicators 156

Generics in India 158

Market Overview 158

Market Data 159

Market Segmentation 161

Market outlook 162

Five forces analysis 164

Macroeconomic indicators 170

Generics in Indonesia 172

Market Overview 172

Market Data 173

Market Segmentation 175

Market outlook 176

Five forces analysis 178

Macroeconomic indicators 184

Generics in Italy 186

Market Overview 186

Market Data 187

Market Segmentation 189

Market outlook 190

Five forces analysis 192

Macroeconomic indicators 198

Generics in Japan 200

Market Overview 200

Market Data 201

Market Segmentation 203

Market outlook 204

Five forces analysis 206

Macroeconomic indicators 212

Generics in Mexico 214

Market Overview 214

Market Data 215

Market Segmentation 217

Market outlook 218

Five forces analysis 220

Macroeconomic indicators 226

Generics in The Netherlands 228

Market Overview 228

Market Data 229

Market Segmentation 231

Market outlook 232

Five forces analysis 234

Macroeconomic indicators 240

Generics in North America 242

Market Overview 242

Market Data 243

Market Segmentation 245

Market outlook 246

Five forces analysis 248

Generics in Russia 255

Market Overview 255

Market Data 256

Market Segmentation 258

Market outlook 259

Five forces analysis 261

Macroeconomic indicators 267

Generics in Scandinavia 269

Market Overview 269

Market Data 270

Market Segmentation 272

Market outlook 273

Five forces analysis 275

Generics in Singapore 281

Market Overview 281

Market Data 282

Market Segmentation 284

Market outlook 285

Five forces analysis 287

Macroeconomic indicators 293

Generics in South Africa 295

Market Overview 295

Market Data 296

Market Segmentation 298

Market outlook 299

Five forces analysis 301

Macroeconomic indicators 307

Generics in South Korea 309

Market Overview 309

Market Data 310

Market Segmentation 312

Market outlook 313

Five forces analysis 315

Macroeconomic indicators 321

Generics in Spain 323

Market Overview 323

Market Data 324

Market Segmentation 326

Market outlook 327

Five forces analysis 329

Macroeconomic indicators 335

Generics in Turkey 337

Market Overview 337

Market Data 338

Market Segmentation 340

Market outlook 341

Five forces analysis 343

Macroeconomic indicators 349

Generics in The United Kingdom 351

Market Overview 351

Market Data 352

Market Segmentation 354

Market outlook 355

Five forces analysis 357

Macroeconomic indicators 364

Generics in The United States 366

Market Overview 366

Market Data 367

Market Segmentation 369

Market outlook 370

Five forces analysis 372

Macroeconomic indicators 378

Company Profiles 380

Leading Companies 380

Appendix 457

Methodology 457

About MarketLine 458

List of Tables

List of Tables

Table 1: Global generics market value: $ billion, 2013-17

Table 2: Global generics market volume: % of total pharma, 2013-17

Table 3: Global generics market geography segmentation: $ billion, 2017

Table 4: Global generics market value forecast: $ billion, 2017-22

Table 5: Global generics market volume forecast: % of total pharma, 2017-22

Table 6: Asia-Pacific generics market value: $ billion, 2013-17

Table 7: Asia-Pacific generics market volume: % of total pharma, 2013-17

Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2017

Table 9: Asia-Pacific generics market value forecast: $ billion, 2017-22

Table 10: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22

Table 11: Europe generics market value: $ billion, 2013-17

Table 12: Europe generics market volume: % of total pharma, 2013-17

Table 13: Europe generics market geography segmentation: $ billion, 2017

Table 14: Europe generics market value forecast: $ billion, 2017-22

Table 15: Europe generics market volume forecast: % of total pharma, 2017-22

Table 16: France generics market value: $ million, 2013-17

Table 17: France generics market volume: % of total pharma, 2013-17

Table 18: France generics market geography segmentation: $ million, 2017

Table 19: France generics market value forecast: $ million, 2017-22

Table 20: France generics market volume forecast: % of total pharma, 2017-22

Table 21: France size of population (million), 2013-17

Table 22: France gdp (constant 2005 prices, $ billion), 2013-17

Table 23: France gdp (current prices, $ billion), 2013-17

Table 24: France inflation, 2013-17

Table 25: France consumer price index (absolute), 2013-17

Table 26: France exchange rate, 2013-17

Table 27: Germany generics market value: $ million, 2013-17

Table 28: Germany generics market volume: % of total pharma, 2013-17

Table 29: Germany generics market geography segmentation: $ million, 2017

Table 30: Germany generics market value forecast: $ million, 2017-22

Table 31: Germany generics market volume forecast: % of total pharma, 2017-22

Table 32: Germany size of population (million), 2013-17

Table 33: Germany gdp (constant 2005 prices, $ billion), 2013-17

Table 34: Germany gdp (current prices, $ billion), 2013-17

Table 35: Germany inflation, 2013-17

Table 36: Germany consumer price index (absolute), 2013-17

Table 37: Germany exchange rate, 2013-17

Table 38: Australia generics market value: $ million, 2013-17

Table 39: Australia generics market volume: % of total pharma, 2013-17

Table 40: Australia generics market geography segmentation: $ million, 2017

Table 41: Australia generics market value forecast: $ million, 2017-22

Table 42: Australia generics market volume forecast: % of total pharma, 2017-22

Table 43: Australia size of population (million), 2013-17

Table 44: Australia gdp (constant 2005 prices, $ billion), 2013-17

Table 45: Australia gdp (current prices, $ billion), 2013-17

Table 46: Australia inflation, 2013-17

Table 47: Australia consumer price index (absolute), 2013-17

Table 48: Australia exchange rate, 2013-17

Table 49: Brazil generics market value: $ million, 2013-17

Table 50: Brazil generics market volume: % of total pharma, 2013-17

Table 51: Brazil generics market geography segmentation: $ million, 2017

Table 52: Brazil generics market value forecast: $ million, 2017-22

Table 53: Brazil generics market volume forecast: % of total pharma, 2017-22

Table 54: Brazil size of population (million), 2013-17

List of Figures

List of Figures

Figure 1: Global generics market value: $ billion, 2013-17

Figure 2: Global generics market volume: % of total pharma, 2013-17

Figure 3: Global generics market geography segmentation: % share, by value, 2017

Figure 4: Global generics market value forecast: $ billion, 2017-22

Figure 5: Global generics market volume forecast: % of total pharma, 2017-22

Figure 6: Forces driving competition in the global generics market, 2017

Figure 7: Drivers of buyer power in the global generics market, 2017

Figure 8: Drivers of supplier power in the global generics market, 2017

Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2017

Figure 10: Factors influencing the threat of substitutes in the global generics market, 2017

Figure 11: Drivers of degree of rivalry in the global generics market, 2017

Figure 12: Asia-Pacific generics market value: $ billion, 2013-17

Figure 13: Asia-Pacific generics market volume: % of total pharma, 2013-17

Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2017

Figure 15: Asia-Pacific generics market value forecast: $ billion, 2017-22

Figure 16: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22

Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2017

Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2017

Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2017

Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2017

Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2017

Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2017

Figure 23: Europe generics market value: $ billion, 2013-17

Figure 24: Europe generics market volume: % of total pharma, 2013-17

Figure 25: Europe generics market geography segmentation: % share, by value, 2017

Figure 26: Europe generics market value forecast: $ billion, 2017-22

Figure 27: Europe generics market volume forecast: % of total pharma, 2017-22

Figure 28: Forces driving competition in the generics market in Europe, 2017

Figure 29: Drivers of buyer power in the generics market in Europe, 2017

Figure 30: Drivers of supplier power in the generics market in Europe, 2017

Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2017

Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2017

Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2017

Figure 34: France generics market value: $ million, 2013-17

Figure 35: France generics market volume: % of total pharma, 2013-17

Figure 36: France generics market geography segmentation: % share, by value, 2017

Figure 37: France generics market value forecast: $ million, 2017-22

Figure 38: France generics market volume forecast: % of total pharma, 2017-22

Figure 39: Forces driving competition in the generics market in France, 2017

Figure 40: Drivers of buyer power in the generics market in France, 2017

Figure 41: Drivers of supplier power in the generics market in France, 2017

Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2017

Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2017

Figure 44: Drivers of degree of rivalry in the generics market in France, 2017

Figure 45: Germany generics market value: $ million, 2013-17

Figure 46: Germany generics market volume: % of total pharma, 2013-17

Figure 47: Germany generics market geography segmentation: % share, by value, 2017

Figure 48: Germany generics market value forecast: $ million, 2017-22

Figure 49: Germany generics market volume forecast: % of total pharma, 2017-22

Figure 50: Forces driving competition in the generics market in Germany, 2017

Figure 51: Drivers of buyer power in the generics market in Germany, 2017

Figure 52: Drivers of supplier power in the generics market in Germany, 2017

Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2017

Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2017

Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2017

Figure 56: Australia generics market value: $ million, 2013-17

Figure 57: Australia generics market volume: % of total pharma, 2013-17

Figure 58: Australia generics market geography segmentation: % share, by value, 2017

    Pricing

Quick Buy
Add to basket Request sample pages

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports